To summarize, our results showed that patients with ASXL1mt manifested with a worse CR rate, and an inferior OS was observed in patients with MDS, co‐mutations of RUNX1, SRSF2, or NRAS, and mutations in G646W. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.